Order Article Reprints

Hachisuga K, Kawakami M, Tomonobe H, Maenohara S, Kodama K, Yagi H, Yasunaga M, Onoyama I, Asanoma K, Yahata H, et al. Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry. Diagnostics. 2025; 15(6):671. https://doi.org/10.3390/diagnostics15060671

Hachisuga, Kazuhisa, Minoru Kawakami, Hiroshi Tomonobe, Shoji Maenohara, Keisuke Kodama, Hiroshi Yagi, Masafumi Yasunaga, Ichiro Onoyama, Kazuo Asanoma, Hideaki Yahata, and et al. 2025. "Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry" Diagnostics 15, no. 6: 671. https://doi.org/10.3390/diagnostics15060671

Hachisuga, K., Kawakami, M., Tomonobe, H., Maenohara, S., Kodama, K., Yagi, H., Yasunaga, M., Onoyama, I., Asanoma, K., Yahata, H., Oda, Y., & Kato, K. (2025). Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry. Diagnostics, 15(6), 671. https://doi.org/10.3390/diagnostics15060671